Salix Pharmaceuticals, Ltd. Reports 1Q2006 Results
RALEIGH, N.C.--(BUSINESS WIRE)--May 4, 2006--Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP - News): Change in 2006 EPS Guidance to Approximately $0.65 Due to Initiatives to Expedite and Strengthen Key R&D Projects
Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP - News) today announced financial and operating results for the quarter ended March 31, 2006.